BDBM22165
 | 105 | 91 | 0 | 0 | 0 | 0 | 0 | 0 | - 15-Lipoxygenase (LoxA)
- 5-HT3A Serotonin Receptor
- 5-hydroxytryptamine receptor 1A
- 5-hydroxytryptamine receptor 2A
- Alpha-1A adrenergic receptor
- Beta-1 adrenergic receptor
- D(1A) dopamine receptor
- D(2) dopamine receptor
- D(3) dopamine receptor
- Delta-type opioid receptor
- Gamma-aminobutyric acid receptor subunit alpha-1
- Histamine H1 receptor
- Kappa-type opioid receptor
- Mu-type opioid receptor
- Muscarinic acetylcholine receptor M2
- Norepinephrine Monoamine transporters
- Norepinephrine transporter
- Potassium voltage-gated channel subfamily H member 2
- SLC6A3
- SLC6A4
- Serotonin receptor 2a and 2c (5HT2A and 5HT2C)
- Sigma non-opioid intracellular receptor 1
- Sodium-dependent dopamine transporter
- Sodium-dependent noradrenaline transporter
- Sodium-dependent serotonin transporter
- Transporter
- Voltage-dependent L-type calcium channel subunit alpha-1C
- adrenergic Alpha2
| - 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine
- CHEMBL153260
- CHEMBL281594
- CHEMBL542933
- CHEMBL543876
- GBR 12909
- GBR-12909
- NCGC00015300
- US9944618, Compound ID No. 175
- Vanoxerine
|